Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

163 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Crisscross CTL induction by SYT-SSX junction peptide and its HLA-A*2402 anchor substitute.
Ida K, Kawaguchi S, Sato Y, Tsukahara T, Nabeta Y, Sahara H, Ikeda H, Torigoe T, Ichimiya S, Kamiguchi K, Wada T, Nagoya S, Hiraga H, Kawai A, Ishii T, Araki N, Myoui A, Matsumoto S, Ozaki T, Yoshikawa H, Yamashita T, Sato N. Ida K, et al. Among authors: hiraga h. J Immunol. 2004 Jul 15;173(2):1436-43. doi: 10.4049/jimmunol.173.2.1436. J Immunol. 2004. PMID: 15240740
Detection and induction of CTLs specific for SYT-SSX-derived peptides in HLA-A24(+) patients with synovial sarcoma.
Sato Y, Nabeta Y, Tsukahara T, Hirohashi Y, Syunsui R, Maeda A, Sahara H, Ikeda H, Torigoe T, Ichimiya S, Wada T, Yamashita T, Hiraga H, Kawai A, Ishii T, Araki N, Myoui A, Matsumoto S, Umeda T, Ishii S, Kawaguchi S, Sato N. Sato Y, et al. Among authors: hiraga h. J Immunol. 2002 Aug 1;169(3):1611-8. doi: 10.4049/jimmunol.169.3.1611. J Immunol. 2002. PMID: 12133991
Identification of human autologous cytotoxic T-lymphocyte-defined osteosarcoma gene that encodes a transcriptional regulator, papillomavirus binding factor.
Tsukahara T, Nabeta Y, Kawaguchi S, Ikeda H, Sato Y, Shimozawa K, Ida K, Asanuma H, Hirohashi Y, Torigoe T, Hiraga H, Nagoya S, Wada T, Yamashita T, Sato N. Tsukahara T, et al. Among authors: hiraga h. Cancer Res. 2004 Aug 1;64(15):5442-8. doi: 10.1158/0008-5472.CAN-04-0522. Cancer Res. 2004. PMID: 15289353
A randomized phase II/III trial of perioperative chemotherapy with adriamycin plus ifosfamide versus gemcitabine plus docetaxel for high-grade soft tissue sarcoma: Japan Clinical Oncology Group Study JCOG1306.
Kataoka K, Tanaka K, Mizusawa J, Kimura A, Hiraga H, Kawai A, Matsunobu T, Matsumine A, Araki N, Oda Y, Fukuda H, Iwamoto Y; Bone and Soft Tissue Tumor Study Group of the Japan Clinical Oncology Group. Kataoka K, et al. Among authors: hiraga h. Jpn J Clin Oncol. 2014 Aug;44(8):765-9. doi: 10.1093/jjco/hyu080. Epub 2014 Jun 10. Jpn J Clin Oncol. 2014. PMID: 24916336 Clinical Trial.
163 results